Bank of America Corporation (BAC) 13D/13G Filings for Concert Pharmaceuticals, Inc. (CNCE)

Bank of America Corporation 13D and 13G filings for Concert Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-01-13
10:20 am
Sale
2021-12-3113GConcert Pharmaceuticals, Inc.
CNCE
BANK OF AMERICA CORP
BAC
1,007,258
2.900%
-870,960decrease
(-46.37%)
Filing
2021-02-08
5:06 pm
Purchase
2020-12-3113GConcert Pharmaceuticals, Inc.
CNCE
BANK OF AMERICA CORP
BAC
1,878,218
6.100%
67,012increase
(+3.70%)
Filing
2020-02-14
12:57 pm
Purchase
2019-12-3113GConcert Pharmaceuticals, Inc.
CNCE
BANK OF AMERICA CORP
BAC
1,811,206
7.600%
1,811,206increase
(New Position)
Filing